Visceral Adiposity Index in Relation to Rotterdam Phenotypes of Polycystic Ovary Syndrome
Open Access
- 16 August 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1997
Abstract
Polycystic ovary syndrome (PCOS) is a hormonal disorder with complex, multifactorial and still not fully explained etiopathogenesis. It is believed that the cause is a combination of genetic and environmental factors. Background: With the aim to better understand PCOS etiology, the study examines body composition and compares the occurrence of lipid disorders and visceral adipose tissue depending on the adopted Rotterdam phenotypes. Methods: The study included 242 patients classified into four classic Rotterdam phenotypes. Clinical data from patients were collected and carefully analyzed to determine the relationship between the occurrence of lipid disorders and the visceral adiposity index (VAI). Results: The results obtained after assessing the differences between the Rotterdam phenotypes were not statistically significant. Differences in the levels of coefficients included in the VAI equation in the given phenotypes were also analyzed, as follows: waist circumference (p-value = 0.3415), BMI (p-value = 0.7112), TG [mmol/L] (p-value = 0.5341) and HDL [mmol/L] (p-value = 0.2302). None of the differences were statistically significant. Conclusions: Although the results did not show a clear association between VAI and the individual Rotterdam PCOS phenotypes, this coefficient can be used in the assessment of cardiometabolic risk in women with PCOS regardless of the adopted classification.Keywords
Funding Information
- Medical University of Silesia (BNW-NWN-640-2-1-316/25, ABM 2023/ABM/02/00018)
- Interdisciplinary Pomeranian Centre for Digital Medicine (BNW-NWN-640-2-1-316/25, ABM 2023/ABM/02/00018)
This publication has 32 references indexed in Scilit:
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2023
- Visceral adiposity index as a predictor of type 2 diabetes mellitus risk: A systematic review and dose–response meta-analysisNutrition, Metabolism and Cardiovascular Diseases, 2023
- A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)Journal of Assisted Reproduction and Genetics, 2022
- Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular diseaseFertility and Sterility, 2022
- Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and ClassificationEndocrine Reviews, 2022
- Interactive Web-Based Data Visualization with R, plotly, and shiny2020
- Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian populationLipids in Health and Disease, 2011
- The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic riskHuman Reproduction, 2011
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952